This company has been marked as potentially delisted and may not be actively trading. Clovis Oncology (CLVS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CLVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Olivier Clovis Scaling Business Launches Sales Funnel Coaching Program to Help Entrepreneurs Scale Online BusinessesSeptember 3, 2025 | globenewswire.comClovis Chamber names new Retail RockstarOctober 9, 2024 | yahoo.comThis 62-year-old man is missing in Clovis, police sayOctober 1, 2024 | yahoo.com‘The main challenge is safety.’ Clinician challenges board president for Clovis Unified trustee seatOctober 1, 2024 | news.yahoo.comNM agencies host informational meeting for future PFAS blood testing in ClovisAugust 27, 2024 | yahoo.comCancer HoroscopeAugust 15, 2024 | usatoday.comCensor lawsuit sees students win case against Clovis Community CollegeAugust 6, 2024 | msn.com3 arrested, 6 cited at Clovis DUI checkpoint, police sayJuly 29, 2024 | msn.comClovis’ mayor is a paid member of the Valley Children’s team: what does she do?March 22, 2024 | msn.comClovis West 'Team Eagles' raises money for Leukemia & Lymphoma SocietyMarch 6, 2024 | msn.comFresno father creates toy drive inspired by son's cancer battle: 'Toys of Hope'December 10, 2023 | msn.comOfficials: Weapon found in backpack at Clovis High SchoolDecember 6, 2023 | msn.comCity of Clovis hosts tree lighting ceremonyNovember 30, 2023 | msn.comFresno hospice nurse diagnosed with stage 4 cancerOctober 24, 2023 | msn.comClovis Oncology (CLVS) Stock Gains in After-Hours Trading After 'Breakthrough Therapy' DesignationJuly 19, 2023 | thestreet.comTesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial ShowsJuly 6, 2023 | thestreet.comWhy Clovis Oncology (CLVS) Stock Hit a One-Year Low TodayJuly 6, 2023 | thestreet.comWing commander receives key to the city of ClovisMay 21, 2023 | news.yahoo.comNo air conditioning at Clovis East High as Fresno temperatures approach triple digitsMay 17, 2023 | news.yahoo.comNon-Metastatic Castration Resistant Prostate Cancer (nmCRPC) Treatment Market Size with Growth Opportunities, Top Countries Data, Future TrendsMay 11, 2023 | marketwatch.comClovis East High SchoolMay 7, 2023 | usnews.comLuteinizing Hormone Releasing Hormone (LHRH) Agonists Market Growth, Business Development and Analysis Till 2029March 22, 2023 | marketwatch.comTo improve representation and safety, Fresno and Clovis schools need student councils | OpinionMarch 22, 2023 | news.yahoo.comSilicon Valley Bank, a 'strong supporter' of Colorado tech startups, closed by regulatorsMarch 12, 2023 | bizjournals.comAnalysts Holding As Pfizer Waits On Two Phase 3 Studies (CLVS)Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.February 24, 2023 | marketbeat.comCLVS.OJanuary 30, 2023 | reuters.comCLVSQ Clovis Oncology, Inc.January 18, 2023 | seekingalpha.comClovis OncologyJanuary 13, 2023 | forbes.comFirm Retention Summary: Clovis Oncology Inc.January 3, 2023 | wsj.comCancer drugmaker Clovis files for bankruptcy, hit by falling salesDecember 12, 2022 | reuters.comThinking about buying stock in Clovis Oncology, Bank of America, Rivian Automotive, Rent the Runway, or Vipshop Holdings?December 12, 2022 | benzinga.comBoulder drugmaker Clovis Oncology files for bankruptcyDecember 12, 2022 | bizjournals.comClovis Plans to Sell Cancer Drug to Novartis in Bankruptcy DealDecember 12, 2022 | finance.yahoo.comClovis (CLVS) Files for Bankruptcy Amid Lack of Financial AidDecember 12, 2022 | finance.yahoo.comClovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to NovartisDecember 12, 2022 | finance.yahoo.comCLVS Stock Alert: What to Know as Clovis Oncology Files for BankruptcyDecember 12, 2022 | investorplace.comCancer Focused Clovis Oncology Files For BankruptcyDecember 12, 2022 | benzinga.comClovis stock slumps amid Chapter 11 filing, to sell FAP-2286 to Novartis for $50M upfrontDecember 12, 2022 | seekingalpha.comClovis Oncology Shares Fall Premarket After Bankruptcy Filing >CLVSDecember 12, 2022 | marketwatch.comClovis Oncology stock slides 10% premarket after company files for bankruptcyDecember 12, 2022 | finance.yahoo.comClovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286December 12, 2022 | finance.yahoo.comU.S. drugmaker Clovis files for Chapter 11 bankruptcyDecember 12, 2022 | finance.yahoo.comUPDATE 1-Cancer drugmaker Clovis files for bankruptcy, hit by falling salesDecember 12, 2022 | finance.yahoo.comDear CLVS Stock Fans, Get Ready for a Bankruptcy FilingDecember 5, 2022 | investorplace.comClovis (CLVS) Stock Down 50% in the Past 6 Months: Here's WhyNovember 25, 2022 | finance.yahoo.comDown 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)November 21, 2022 | finance.yahoo.comClovis Oncology (CLVS) Stock Pops After Bankruptcy WarningNovember 14, 2022 | investorplace.comClovis Oncology Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagNovember 11, 2022 | finance.yahoo.comClovis Oncology Shares Nose-Dive As Potential Bankruptcy Filing LoomsNovember 9, 2022 | finance.yahoo.comClovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023November 9, 2022 | finance.yahoo.com Get Clovis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLVS Media Mentions By Week CLVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLVS News Sentiment▼0.000.93▲Average Medical News Sentiment CLVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLVS Articles This Week▼00▲CLVS Articles Average Week Get the Latest News and Ratings for CLVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Clovis Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SAB Biotherapeutics News Curis News Bolt Biotherapeutics News Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Regeneron Pharmaceuticals News Biogen News United Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLVS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clovis Oncology Please log in to your account or sign up in order to add this asset to your watchlist. Share Clovis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLVS Stock Alerts